Study of potential new treatment for mesothelioma open to patients

September 15, 2016

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke's Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy.

Pleural mesothelioma is a rare and aggressive that develops in the pleura, a thin layer of tissue that surrounds the lungs. The most common cause of malignant pleural mesothelioma is exposure to industrial pollutants, predominantly asbestos, a fiber-like material that was used in some industries before its toxic qualities were understood. This disease affects people who were exposed to asbestos in the workplace and their family members.

"The disease is particularly challenging because by the time it's detected – often 20 to 40 years after exposure to the cancer-causing asbestos – the disease can be very advanced," said Dr. David Sugarbaker, professor of surgery, chief of the division of thoracic surgery and director of the Mesothelioma Treatment Center and Lung Institute at Baylor. "Currently, available treatment options are limited for patients whose mesothelioma has progressed or does not respond after initial anticancer treatment, so clinical research is highly important in helping advance our understanding of how to treat it."

The purpose of this Phase II clinical study is to assess the safety and effectiveness of an investigational cancer drug versus a commonly used medication in people with that has advanced and/or metastasized and that is refractory (stopped responding or did not respond to previous ). This binds to a protein called mesothelin, which can be found on the surface of some cancer cells, and releases chemotherapy to the tumor to try to slow or stop the growth of cancer cells.

The investigational drug is currently only available through studies such as this one.

Explore further: Mesothelioma surgery improves quality of life

More information: Details about this clinical study can be found online: clinicaltrials.gov/ct2/show/NC … ab+ravtansine&rank=4

Related Stories

Mesothelioma surgery improves quality of life

June 9, 2016
Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life.

Researchers find potential new target to treat malignant pleural mesothelioma

July 25, 2013
Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options. Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis. Increased understanding ...

Renal cancer drug temsirolimus shows promise against mesothelioma

May 1, 2011
A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Statistical model may identify patients most likely to benefit from surgery for mesothelioma

September 8, 2015
A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in the September 2015 issue ...

Overlooked lymph nodes in rib cage have prognostic power for mesothelioma patients

October 28, 2013
For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes—known as the posterior intercostal lymph nodes—that ...

Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

April 20, 2015
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the ...

Recommended for you

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Promising new treatment for rare pregnancy cancer leads to remission in patients

November 24, 2017
An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.